Mitsubishi UFJ Morgan Stanley Securities’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-10
Closed -$3K – 202
2022
Q3
$3K Hold
10
– – 0.04% 158
2022
Q2
$4K Hold
10
– – 0.01% 154
2022
Q1
$5K Sell
10
-30
-75% -$15.8K ﹤0.01% 149
2021
Q4
$26K Sell
40
-50
-56% -$31.4K 0.01% 118
2021
Q3
$56K Sell
90
-40
-31% -$26.9K 0.05% 64
2021
Q2
$82K Buy
+130
New +$71.8K 0.61% 32

Other funds holding IDXX

Mitsubishi UFJ Morgan Stanley Securities's IDXX Position: Q4 2022 in Review

Mitsubishi UFJ Morgan Stanley Securities sold out of Idexx Laboratories (IDXX) in Q4 2022, closing a stake of 10 shares — an estimated $3K sold.

Mitsubishi UFJ Morgan Stanley Securities first reported a position in IDXX in Q2 2021 and held it in 6 quarters. The position peaked at $82K in Q2 2021. 999 funds tracked by Wall St. Rank hold IDXX as of Q4 2022.

  • Mitsubishi UFJ Morgan Stanley Securities reported no remaining Idexx Laboratories position as of Q4 2022 after selling out during the quarter.
  • Mitsubishi UFJ Morgan Stanley Securities sold 10 Idexx Laboratories shares in Q4 2022, an estimated $3K.
  • Mitsubishi UFJ Morgan Stanley Securities first reported a position in Idexx Laboratories in Q2 2021 and held it in 6 quarters.
  • Mitsubishi UFJ Morgan Stanley Securities's Idexx Laboratories position peaked at $82K in Q2 2021.
  • 999 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2022.

Based on Mitsubishi UFJ Morgan Stanley Securities's 13F filing for Q4 2022, filed 24 Jan 2023.